sarcomatoid carcinoma lung term encompasses five distinct histological subtypes lung cancer including pleomorphic carcinoma spindle cell carcinoma giant cell carcinoma carcinosarcoma pulmonary abnormal duplication egfr gene relatively infrequent phenomenon scl copies cells overexpression egfr protein occurs nearly cases mutations egfr gene relatively rare kras mutations found cases cases scl show intense immune infiltration predominantly neutrophillic however tumors evade immune system increased expression negative regulator tcells mainly programmed death lung cancer large exceptionally heterogeneous family different histological variants explicitly recognized within revision world health organization typing system currently widely used lung cancer classification many entities rare recently described poorly however since different forms malignant tumors generally exhibit diverse genetic biological clinical properties including response treatment accurate classification lung cancer cases critical assuring patients lung cancer receive optimum approximately lung cancers carcinoma term malignant neoplasms derived cells epithelial lineage andor exhibit cytological tissue architectural features characteristically found epithelial lung carcinomas divided major sarcomatoid carcinomas unique among lung carcinomas although considered carcinomas contain cytological tissue architectural features usually characteristic tumors rare randomized clinical trials yet conducted respect specific treatment regimens histospecific studies individual subtypes scl published literature data small retrospective case series case reports many cases scl generally treated like nsclc however scl considered particularly aggressive nonsmall cell lung experts recommend particularly aggressive treatment approach tumors little known effects egfr inhibitors sc although evidence suggests tumors likely highly group scl prognosis considered worse types nsclccitation needed httpsenwikipediaorgwikisarcomatoidcarcinomaofthelung